RS
Regina Salvat
OtherActivePrincipal at Sofinnova Investments
Cambridge, United StatesFounded 2015
67
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Regina Salvat.
Investment Thesis & Strategy
Regina Salvat, as a principal at Sofinnova Investments, invests in various stages of biotech, consumer health, healthcare, health & hospital services, and health IT companies. She likely seeks innovative companies with strong growth potential within the healthcare and life sciences sectors.
Portfolio Companies
Selected investments from their portfolio of 67 companies
D
Dauntless Pharmaceuticals
Other · , 0
A
Aeovian Pharmaceuticals
Biotech · Seed, 0
P
Principia Biopharma
Biotech · Series B, 0
I
Innocoll Holdings
Biotech · Series A, 0
Q
Quanta Therapeutics
Biotech · Series A, 0
N
NuCana BioMed
Biotech · Series A, 0
Z
ZS Pharma
Biotech · Series A, 0
N
NextCure
Biotech · Series A, 0
C
ConteXtream
Enterprise · Seed, 0
C
Chiasma
Biotech · Series A, 0
A
Aclaris Therapeutics
Biotech · Series A, 0
V
Vera Therapeutics
Biotech · Series B, 0
Frequently Asked Questions
Regina Salvat focuses on Seed, Pre-seed stage investments.